ロード中...
Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass
Use of argatroban as an alternative to heparin during cardiopulmonary bypass (CPB) in patients with heparin-induced thrombocytopenia has gained some attention in the past two decades. Dosing of argatroban during CPB is complex due to lack of complete understanding of its pharmacokinetic profile and...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3275940/ https://ncbi.nlm.nih.gov/pubmed/22345956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-9185.92458 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|